Global GABA (CAS 56-12-2) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global GABA (CAS 56-12-2) market size will reach 104.86 Million USD in 2025 and is projected to reach 162.74 Million USD by 2032, with a CAGR of 6.48% (2025-2032). Notably, the China GABA (CAS 56-12-2) market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

GABA, or gamma-aminobutyric acid, is a naturally occurring neurotransmitter in the central nervous system of mammals, including humans. Its chemical formula is C₄H₉NO₂. GABA functions as an inhibitory neurotransmitter, meaning it regulates and reduces the activity of neurons in the brain and spinal cord. It plays a crucial role in controlling anxiety and stress levels, promoting relaxation and sleep. GABA is involved in the regulation of mood and has been implicated in various neurological conditions, such as anxiety disorders and epilepsy. The CAS (Chemical Abstracts Service) number for GABA is 56-12-2, serving as a unique identifier for this compound in chemical databases and literature. GABA is also available as a dietary supplement, and its potential role in promoting relaxation has led to its use in various health and wellness products.

The major global  manufacturers of GABA (CAS 56-12-2) include Pharma Foods International, Kyowa Hakko, Sekisui Chemical, Sino Biotek, Zhejiang Yiwan Bio, Shanghai Richen, Luckerkong, Qandr Biology, Jyswkj, Bloomage Biotech, Zjtr Chemistry, Xinyou Chemistry, Huarui Biology, Bornsun Biology, Viab Life, Microbiofeed, Harworld, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of GABA (CAS 56-12-2). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global GABA (CAS 56-12-2) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the GABA (CAS 56-12-2) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of GABA (CAS 56-12-2) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of GABA (CAS 56-12-2) Include:

Pharma Foods International

Kyowa Hakko

Sekisui Chemical

Sino Biotek

Zhejiang Yiwan Bio

Shanghai Richen

Luckerkong

Qandr Biology

Jyswkj

Bloomage Biotech

Zjtr Chemistry

Xinyou Chemistry

Huarui Biology

Bornsun Biology

Viab Life

Microbiofeed

Harworld

GABA (CAS 56-12-2) Product Segment Include:

Microbial Fermentation (Feed Grade)

Microbial Fermentation (Food Grade)

Chemical Synthesis

GABA (CAS 56-12-2) Product Application Include:

Animal Feed

Food

Medicine

Plant Growth Promoter

Cosmetic

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global GABA (CAS 56-12-2) Capacity and Production Analysis

Chapter 3: Global GABA (CAS 56-12-2) Industry PESTEL Analysis

Chapter 4: Global GABA (CAS 56-12-2) Industry Porter's Five Forces Analysis

Chapter 5: Global GABA (CAS 56-12-2) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 6: Global GABA (CAS 56-12-2) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 7: Global GABA (CAS 56-12-2) Sales, Revenue, Price and Forecast by Product Type

Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 9: Industrial Chain Analysis, GABA (CAS 56-12-2) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 10: Research Findings and Conclusion

Chapter 11: Methodology and Data Sources Show more